Corporate Disclosure

NOTitleAuthorDate
46 Additional Listing(우리사주매수선택권 행사) HUGEL 2017.08.30 18:03
45 Additional Listing(유상증자(제3자배정)) HUGEL 2017.07.28 17:59
44 Report on Business Performance according to Consolidated Financial Statements (Fair Disclosure) HUGEL 2017.07.25 16:11
43 Change of CEO HUGEL 2017.07.14 16:48
42 Results of Extraordinary Shareholders' Meeting HUGEL 2017.07.14 16:46
41 Results of issuance(Voluntary Disclosure)(제3자배정 유상증자) HUGEL 2017.07.14 16:45
40 Change of The Largest Shareholder HUGEL 2017.07.14 16:45
39 Results of issuance(Voluntary Disclosure)(제2회차 CB) HUGEL 2017.07.14 16:45
38 [Revised] Decision on Calling Shareholders` Meeting HUGEL 2017.06.29 16:35
37 [Revised] Decision on Paid-in Capital Increase(제3자배정) HUGEL 2017.06.05 17:48
36 [Revised] Decision on Issuing of Convertible Bonds(제2회차) HUGEL 2017.06.05 17:48
35 Decision on Calling Shareholders` Meeting HUGEL 2017.06.05 17:39
34 Material Management Information related to Judgment of Investment(최대주주인 명목회사(동양에이치씨)의 최대주주 변경을 수반하는 주식 양수도 계약 체결) HUGEL 2017.06.05 17:38
33 Report on Business Performance according to Consolidated Financial Statements (Fair Disclosure) HUGEL 2017.04.27 08:16
32 Decision on Issuing of Convertible Bonds(제2회차) HUGEL 2017.04.17 08:10
31 Decision on Paid-in Capital Increase(제3자배정) HUGEL 2017.04.17 07:54
30 Material Management Information related to Judgment of Investment(포괄적 경영권 양수도 거래) HUGEL 2017.04.17 07:04
29 Change of CEO HUGEL 2017.04.03 16:26
28 Outcome of Annual Shareholders` Meeting HUGEL 2017.03.28 16:09
27 Submission of Audit Report HUGEL 2017.03.20 15:23
26 30% or More Change in Sales or Profit/Loss(15% or more in the case of large-scale corporations) HUGEL 2017.02.27 17:30
25 Decision on Calling Shareholders` Meeting HUGEL 2017.02.27 17:21
24 Court Ruling on Lawsuit, etc. HUGEL 2017.02.27 17:19
23 Other Management Information(Voluntary Disclosure)(보툴렉스(Botulax) 브라질 판매허가 획득) HUGEL 2017.02.07 13:31
22 Filing or Application of Lawsuit, etc. (the Corporate Control Contest) HUGEL 2017.01.25 17:44
21 Material Management Information related to Judgment of Investment(비대흉터 치료제(BMT101)의 임상 1상 시험 승인) HUGEL 2017.01.24 15:51
20 Other Management Information(Voluntary Disclosure)(보툴렉스(Botulax) 러시아 판매허가 획득) HUGEL 2016.12.06 14:22
19 [Revised] Decision on Acquisition of Treasury Stocks HUGEL 2016.11.29 09:07
18 Decision on Acquisition of Treasury Stocks HUGEL 2016.11.29 07:10
17 Organization of Investor Relations Event HUGEL 2016.11.23 13:32
16 [Investment Caution] Issue traded by linked accounts with high market influence HUGEL 2016.11.08 16:32
15 Report on Business Performance according to Consolidated Financial Statements (Fair Disclosure) HUGEL 2016.10.26 08:47
14 Prior Notice on Disclosure of Final Earnings HUGEL 2016.10.20 08:54
13 Report on Business Performance according to Consolidated Financial Statements (Fair Disclosure) HUGEL 2016.08.16 16:12
12 Material Management Information related to Judgment of Investment(보툴렉스(Botulax)의 중국 임상 3상 시험 승인) HUGEL 2016.05.27 15:24
11 Procedure of Clinical trials(Voluntary Disclosure) HUGEL 2016.04.07 09:54
10 Outcome of Annual Shareholders` Meeting HUGEL 2016.03.25 17:12
9 Procedure of Clinical trials(Voluntary Disclosure) HUGEL 2016.03.21 15:16
8 Submission of Audit Report HUGEL 2016.03.17 17:09
7 [Investment Caution]small number of branches being focused on HUGEL 2016.03.04 16:38
6 30% or More Change in Sales or Profit/Loss(15% or more in the case of large-scale corporations) HUGEL 2016.02.23 17:42
5 Decision on Calling Shareholders` Meeting HUGEL 2016.02.23 17:42
4 [Revised] Procedure of Clinical trials(Voluntary Disclosure) HUGEL 2016.01.11 10:02
3 Procedure of Clinical trials(Voluntary Disclosure) HUGEL 2016.01.08 17:35
2 Notification of calculation method of determining opening prices on the first trading day(신규상장) HUGEL 2015.12.23 13:44
1 Newly listed (stocks) HUGEL 2015.12.22 16:32